Of note, in hepatocytes, GDF15 expression is considered to be promoted by interleukin (IL)-1β signaling and ER stress which are involved in MASLD development and progression [58, 59]. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.